OncoMate MSI Dx Wins FDA Nod as Keytruda Test for MSI-H Tumors
FDA approves Promega OncoMate MSI Dx as a companion diagnostic for Keytruda in MSI-H solid tumors: how the 5-marker PCR test works and what the data show.
FDA approves Promega OncoMate MSI Dx as a companion diagnostic for Keytruda in MSI-H solid tumors: how the 5-marker PCR test works and what the data show.